Sean Saint - Jan 29, 2025 Form 4 Insider Report for Beta Bionics, Inc. (BBNX)

Role
President & CEO, Director
Signature
/s/ Stephen Feider, Attorney-in-Fact
Stock symbol
BBNX
Transactions as of
Jan 29, 2025
Transactions value $
$0
Form type
4
Date filed
1/31/2025, 04:35 PM
Next filing
Feb 3, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BBNX Employee Stock Option (right to buy) Award $0 +468K $0.00 468K Jan 29, 2025 Class B Common Stock 468K $17.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vesting is monthly over a 48-month period starting January 29, 2025 in equal monthly amounts.
F2 Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock.